Skoulidis et al. recently reported three subsets (KL, KP, and KC subtypes) of KRAS-mutant lung adenocarcinoma cell lines according to the co-occurring genetic events as determined by an integrative analysis of genomic, transcriptomic, and proteomic data [26]. The gene discussed is KRAS; the disease is keratoconus.